Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Antibiotics image

Antibiotic resistance could kill 10 million a year

December 11, 2014 Research and Development, Sales and Marketing Antibiotics, Cancer, KPMG, Merck, david cameron, rand

Antibiotic-resistant bacteria will kill an extra 10 million people a year by 2050 if the problem is not tackled soon, …
News
Sanofi image

Sanofi looking to diversify, may buy into animal health

December 11, 2014 Manufacturing and Production, Research and Development, Sales and Marketing EFPIA, Jimenez, Sanofi, Serge Weinberg, Viehbacher, animal health

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …
News
Takeda image

Takeda eyes new drug licences following positive blood cancer studies

December 11, 2014 Research and Development, Sales and Marketing Adcetris, Takeda, Velcade, ash, bortezomib, brentuximab vedotin, hematology

Takeda is bringing its biotech arm in-house to create a global oncology business unit, which it says will drive forward …
News
Tamoxifen image

Tamoxifen found to reduce breast cancer rates by 30%

December 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arimidex, NICE, anastrozole, astrazenea, breast cancer, tamoxifen

A study from Queen Mary University has demonstrated that tamoxifen can reduce breast cancer rates by around 30% over 20 …
News
kim_lemon

Kim Lemon named head of Liberation Unlimited

December 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, kim lemon, liberation unlimited

Marketing communications agency Liberation Unlimited has appointed Kim Lemon to head its operations. Since the UK-based comms firm joined the …
Appointment
Onyx pharma image

Treatment shifts away from chemotherapy for multiple myeloma

December 10, 2014 Research and Development, Sales and Marketing Kyprolis, carfilzomib, chemotherapy, myeloma, onyx pharmaceuticals

Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …
News
NHS image

Labour to extend cancer drugs funding if elected

December 10, 2014 Research and Development, Sales and Marketing CDF, Cancer, Labour, NHS, NICE, andy burnham, election

Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …
News
michel-de-rosen

Pharnext adds industry veteran to board

December 10, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michel de Rosen, pharnext

France-based clinical stage biopharma firm Pharnext has appointed Michel de Rosen to its board of directors. For nearly 25 years …
Appointment
bayer_healthcare

Mixed results for new leukaemia drugs

December 9, 2014 Research and Development, Sales and Marketing AML, Bayer, Nexavar, Qinprenzo, Sunesis Pharmaceuticals, sorafenib

Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …
News

Pfizer buys into gene therapy

December 9, 2014 Research and Development, Sales and Marketing London, Pfizer, gene therapy, haemophilia, spark, therapeutics

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …
News
bio_wim_sep_2014

Celgene appoints new UK general manager

December 9, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Wim Souverijns

Celgene has appointed Wim Souverijns as its new vice president and general manager for UK and Ireland. Souverijns (pictured) takes …
Appointment
People image

The valuable world of Real World Evidence

December 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, data, martin goldman, real world evidence, transparency

What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …
Feature
james_christie_abpi

ABPI appoints first manufacturing director

December 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, James Christie

The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …
Appointment
Amgen image

Speedy FDA nod for Amgen leukaemia drug

December 5, 2014 Research and Development, Sales and Marketing B-cell lymphoblasts, FDA, Kyprolis, blinatumomab, blincyto, leukaemia

The FDA has approved Amgen’s Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukaemia (B-cell ALL). …
News
screen_shot_2014-12-05_at_08

IDEA Pharma appoints two vice presidents

December 5, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90px, IDEA Pharma, kelly, weston

IDEA Pharma has hired both Samantha Weston and Paul Kelly as vice presidents in business development to boost the company’s …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026